Much has been said in recent months about the need for a third dose of the vaccine against covid-14 so that the antibody rate is not reduced. With this, studies have been carried out to prove the effectiveness of the measure. One of them, carried out in Israel, found that the booster dose actually further reduces the risk of developing the severe form of the disease.
- Vaccination with CoronaVac is suspended in Rio for lack of available doses
- At least 12 Brazilian capitals continue covid vaccination in adolescents
- Research shows that CoronaVac is effective in people with comorbidities
According to the study, in about 12 days or more after the application of the booster dose of the Pfizer vaccine, the chances of infection with the coronavirus, including the Delta variant, dropped by , 4 times compared to those who received only two doses of the immunizing agent. The research also showed that the third dose reduces by 12 times the chances of infection by SARS-CoV -two.
Two-dose vaccination in Israel was completed at the end of March, considerably reducing cases of infection. However, with the arrival of the Delta variant, the numbers increased again, requiring a third dose booster. Now, the country is already preparing for a possible fourth dose.
Did you like this article?
Subscribe your email on Canaltech to receive daily updates with the latest news from the world of technology.